Efficacy of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) chewable tablets in the prevention of Borrelia burgdorferi transmission from infected Ixodes scapularis in dogs

Credelio Quattro™(洛替拉纳、莫昔克丁、吡喹酮和吡喹酮咀嚼片)和 Credelio™(洛替拉纳)咀嚼片在预防犬类感染的肩胛硬蜱传播伯氏疏螺旋体方面的疗效

阅读:1

Abstract

BACKGROUND: Borrelia burgdorferi, the causative agent of Lyme disease, is a zoonotic vector-borne pathogen transmitted by various Ixodes tick species. Lyme disease, while commonly asymptomatic, can induce fever and intermittent lameness in dogs. Highly effective acaricidal products with a rapid onset of action along with prompt removal of attached ticks are important aspects of successful Lyme disease prevention strategies. METHODS: Two studies were conducted with a total of 30 dogs each. Dogs were randomized to receive a control sham dose, Credelio Quattro, or Credelio. Treatment was administered on Day 0 in a fed state. On Day 28, all dogs were experimentally infested with wild-caught adult Ixodes scapularis. Blood samples for B. burgdorferi antibody analysis utilizing the SNAP 4Dx Plus and Lyme Quant C(6) tests were collected on Days 27, 49, 63, 77, 91, and 105. Skin biopsies were collected from four different areas of heavy tick attachment from each dog for polymerase chain reaction (PCR) detection of B. burgdorferi on Day 104 or 105. RESULTS: All control dogs demonstrated adequate I. scapularis infestation rates on Day 33 in both studies. In Study 2, on Day 27, one control dog tested positive for B. burgdorferi on the Lyme Quant C(6) test, prior to experimental tick infestation, and therefore was excluded from analysis. A total of eight out of 10 (Study 1) and nine out of nine (Study 2) control dogs tested positive for B. burgdorferi on at least one test after Day 27. One dog in the Credelio Quattro-treated group tested positive for B. burgdorferi on SNAP 4Dx Plus on Day 105 in Study 1 but was negative on all other tests and study days. None of the dogs treated with Credelio tested positive for B. burgdorferi at any point during either study. CONCLUSIONS: The laboratory studies described herein confirm that a single dose of lotilaner, at the minimum effective dosage of 20 mg/kg, administered as Credelio Quattro, in combination with moxidectin, praziquantel, and pyrantel or Credelio, is effective for the prevention of transmission of B. burgdorferi from infected I. scapularis for a full month in dogs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。